Latest Tax News

Catalyst Metals has cut FY27 production guidance to 90,000-105,000 ounces after deferring Trident and Old Highway output to FY28. The downgrade comes despite a stronger balance sheet, a 2Moz Plutonic Reserve base and A$40 million of quarterly cash generation.

Decidr AI Industries reported a sharp quarterly fall in its invoicing-based AER, even as customer receipts reached a record and Sugarwork’s qualified pipeline expanded. The company is relying on A$11 million of annualised cost reductions and upcoming product launches to extend its runway and convert enterprise interest into recurring revenue.

Nanollose has narrowed its microbial cellulose scale-up plan to one company-controlled Western Australian pilot facility, with all Stage 1 equipment ordered and paid for. The progress comes with a clear funding constraint: the ASX-listed biomaterials developer ended September with $758,000 in cash, equivalent to 1.41 quarters of funding at its current operating burn.

Hydralyte LLC recorded its first monthly operating profit in August, while a major cost reset cut its quarterly operating loss to US$66,900. But revenue fell 21.9%, cash narrowed to US$173,400 and the company is seeking up to A$1.4 million through a rights issue.

Bio-Gene Technology has moved closer to two commercialisation milestones, with Qcide product work progressing in Japan and a first Flavocide regulatory submission targeted for Q2 2027. The company ended September with A$2.103 million in cash, equivalent to an estimated 2.18 quarters of funding at the quarter’s operating cash rate.

Emerald Resources delivered lower September-quarter production but generated A$112.4 million in pre-tax operating cash flow as its Cambodian mine sold gold at an average US$4,255 an ounce. The company kept FY27 guidance unchanged, advanced construction work at Dingo Range and Memot, and opened a potential US$400 million acquisition funding pathway.

Iondrive’s updated model points to a US$243 million post-tax NPV for its proposed Oklahoma rare earth module, but the headline economics now face their first substantial bulk-scale test. The company is targeting 1.4 tonnes of mixed rare earth oxides from a North American qualification campaign while pursuing debt, grants and incentives.

Beacon Minerals delivered a stronger September quarter, producing 6,250 ounces and recording A$21.6 million in net mine cash flow as throughput improved at its Jaurdi mill. The next test is whether the upgraded plant can sustain higher processing rates while the company advances its larger Iguana growth plan.

Ambertech has reported a $2.251 million FY26 statutory loss after taking about $3.2 million in goodwill, inventory and restructuring charges. Cash flow and inventory improved, but the ASX-listed technology distributor will not pay a final dividend as it turns FY27 into an execution test.

Nexalis Therapeutics ended September with $371,000 in cash, equivalent to just 0.9 quarters of funding at its recent operating burn. The company has settled its dispute with Linlithgow Family Office, but its clinical programs remain paused while it pursues R&D tax funding and a new capital raise.

Wrkr’s platform activity accelerated sharply in the first quarter of Payday Super, with contributing TFNs nearly tripling and estimated ARR reaching A$17 million. The next test is converting that adoption into transaction revenue while bringing cash costs down.

CAR Group enters FY27 with double-digit growth expectations after reporting A$1.253 billion in pro forma revenue and 100% EBITDA-to-cash conversion for FY26. Its next growth phase centres on AI agents, proprietary vehicle data and new products across its global marketplaces.